Zeiss Acquires Xradia - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Zeiss Acquires Xradia



Zeiss announced that the acquisition of U.S.-based Xradia, Inc. has been completed and Xradia is now operating under the name of Carl Zeiss X-ray Microscopy, Inc. The acquisition further strengthens the position of the ZEISS Microscopy business group, a manufacturer of light, electron, and X-ray microscopes, with solutions for research and routine inspection in materials and life sciences application fields, the company reports in a press statement.

Zeiss says reports the company will leverage its sales force to make the X-ray technology more accessible in a broader range of applications and workflows. Customers will also benefit from direct service capabilities at multiple locations globally.

http://www.zeiss.de/press/pr0039477b

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
25%
Oversee medical treatment of patients in the US.
13%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here